Crossmark

Margin for compensating displacement of adrenal gland metastasis and fiducial marker along with respiratory phase in real-time motion-tracking radiation therapy

Crossref DOI link: https://doi.org/10.1007/s12194-025-00960-9

Published Online: 2025-09-05

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Aoyama, Yuki https://orcid.org/0000-0002-7477-7803
Tomida, Tetsuya

Nagata, Susumu

Muramatsu, Noriaki

Nakada, Ryosei

Harada, Hideyuki
License Information

Text and Data Mining valid from 2025-09-05

Version of Record valid from 2025-09-05
More Information

Article History

Received: 15 April 2025

Revised: 26 August 2025

Accepted: 28 August 2025

First Online: 5 September 2025

Declarations

:

: This study was approved by the Ethical Review Board of Shizuoka Cancer Center (approval number: J2024-9-2024-1). Patient consent was given in the form of an open document.

: The authors have no relevant financial or non-financial interests to disclose.

Document is current

Any future updates will be listed below